Bioinformatics comes further into spotlight with Illumina, Qiagen buys

Recent acquisitions by two significant molecular diagnostics players in the bioinformatics space highlight its increasing importance, according to Goldman Sachs analyst Isaac Ro.

Recent acquisitions by two significant molecular diagnostics players in the bioinformatics space highlight its increasing importance, according to Goldman Sachs analyst Isaac Ro.

Next-generation genome sequencing leader Illumina has agreed to buy privately-held NextBio (Santa Clara, California) for an undisclosed fee

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight